… stem cell transplantation with a melphalan-based conditioning regimen has become standard
treatment in younger myeloma patients … with stem cell support in myeloma patients with …

… with transplantation failure. Given the improved outcome for WAS patients following
transplantation from an unrelated donor, we conclude that patients with WAS should receive SCT as …

… chemotherapy (HDT) followed by autologous stem cell transplantation (ASCT) is the most
successful therapeutic approach for patients with chemosensitive relapsed DLBCL. With the …

… outcome after stem-cell transplantation. Mutations of ≥ one of these genes were found in
nearly … half of patients in this cohort. Mutations of other genes associated with poor prognosis in …

… with AL amyloidosis with high-dose melphalan and autologous stem cell transplantation (HDM/…
of treatment with HDM/SCT, here we report on the outcome for AL amyloidosis patients …

… patients undergoing allogeneic stem-cell transplantation (allo-SCT) after myeloablative
conditioning (MAC). The purpose was to determine whether EN improves early outcome after …

… transplantation outcomes may be due to a difference in the distribution of the cytogenetic risk
groups. The transplantation outcomes for patients … The results, however, are in accordance …

… of enteral nutrition on early outcome of patients after myeloablative allogeneic stem cell
transplantation (allo-SCT). From January 2001 to January 2003, 22 patients agreed to receive …

… with AKI often have high mortality. This investigation analyzed the outcomes of patients
receiving allogeneic HSCT and identified the association between prognosis and RIFLE (risk of …

… advances have been made in the treatment of AL. The first major advance was the introduction
of high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) [4]. …